EcoDrugPlus

Somatostatin Receptor 4

Ensembl ID : ENSJJAG00000023336
Gene Symbol: SSTR4
3 Cross references
100 Possible Orthologues:

Somatostatin Receptor 5

Ensembl ID : ENSJJAG00000012224
Gene Symbol: SSTR5
3 Cross references
256 Possible Orthologues:

Sphingosine Kinase 2

Ensembl ID : ENSJJAG00000013451
Gene Symbol: SPHK2
3 Cross references
209 Possible Orthologues:

Sphingosine-1-Phosphate Receptor 1

Ensembl ID : ENSJJAG00000010551
Gene Symbol: S1PR1
3 Cross references
200 Possible Orthologues:

Spleen Associated Tyrosine Kinase

Ensembl ID : ENSJJAG00000004667
Gene Symbol: SYK
3 Cross references
200 Possible Orthologues:

Steroid 17-Alpha-Hydroxylase/17,20 Lyase

Ensembl ID : ENSJJAG00000020313
Gene Symbol: LOC101601630
3 Cross references
210 Possible Orthologues:

Steroid 5 Alpha-Reductase 2

Ensembl ID : ENSJJAG00000017180
Gene Symbol: SRD5A2
3 Cross references
263 Possible Orthologues:

Sterol O-Acyltransferase 1

Ensembl ID : ENSJJAG00000019568
Gene Symbol: SOAT1
3 Cross references
210 Possible Orthologues:

Sucrase-Isomaltase

Ensembl ID : ENSJJAG00000013935
Gene Symbol: SI
3 Cross references
200 Possible Orthologues:

Synuclein Alpha

Ensembl ID : ENSJJAG00000006947
Gene Symbol: SNCA
3 Cross references
189 Possible Orthologues:

Tachykinin Receptor 1

Ensembl ID : ENSJJAG00000009094
Gene Symbol: TACR1
3 Cross references
267 Possible Orthologues:

Tachykinin Receptor 2

Ensembl ID : ENSJJAG00000023714
Gene Symbol: TACR2
3 Cross references
199 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).